Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$206.39 - $268.73 $6,604 - $8,599
32 Added 0.57%
5,684 $1.17 Million
Q1 2024

May 06, 2024

SELL
$203.52 - $273.43 $407 - $546
-2 Reduced 0.04%
5,652 $1.53 Million
Q4 2023

Feb 08, 2024

SELL
$164.52 - $238.84 $9,048 - $13,136
-55 Reduced 0.96%
5,654 $1.34 Million
Q3 2023

Nov 08, 2023

BUY
$194.44 - $217.61 $1.11 Million - $1.24 Million
5,709 New
5,709 $1.12 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Amg National Trust Bank Portfolio

Follow Amg National Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amg National Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amg National Trust Bank with notifications on news.